Skip to main content
Pics and it didn’t happen
Fraud in Alzheimer’s research raises difficult questions about the current state of science, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
GROUP SUPREMACY: Alois Alzheimer (standing third from right) with his research group at the Nervenklinik in Munich 1909-1910

IN MOST cases of peer review, scientists review a paper for free while the publisher makes a huge profit margin. Two of the world’s biggest academic publishers are Springer Nature and Elsevier: their recent profit margins range from 28 to 38 per cent. The fees charged by these publishers are generally paid for by research grants; in Britain, that is mostly public money. The status quo of science is worth a lot of money — for some. 

However, not everything that is peer-reviewed is valid. A recent book published this month, Charles Piller’s Doctored, covers the story of fraud in research on Alzheimer’s disease — all of which had been peer-reviewed.

One of the leading theories in the late 20th century about Alzheimer’s was that the accumulation of amyloid proteins was to blame. Amyloids, named after their resemblance to starch molecules, clump together into tangles of gunk in the brain.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
More from this author
POISON: Centivax workers study antivenom to counteract the bites of various snakes at the company lab in San Francisco
Science and Society / 7 May 2025
7 May 2025

A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

SCIENCE AND SOCIETY / 22 April 2025
22 April 2025

Science has always been mixed up with money and power, but as a decorative facade for megayachts, it risks leaving reality behind altogether, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

(Left) Human embryonic stem cells; (right) A patient after i
Features / 26 March 2025
26 March 2025
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries
MORE THAN A WATERWAY: The Agua Clara (Clear Water) locks on
Science and Society / 12 March 2025
12 March 2025
Man-made canals like Panama and Suez face unprecedented challenges from extreme weather patterns and geopolitical tensions that reveal the fragility of our global trade networks, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
Similar stories
An elderly woman's hands
Britain / 22 August 2024
22 August 2024
Full Marx / 29 July 2024
29 July 2024
Most phenomena have an explanation, writes the MARX MEMORIAL LIBRARY, but occasionally ‘anomalous’ events have led to new scientific understanding